In the rapidly evolving landscape of genomics, the Whole Exome Sequencing Market is emerging as a powerful force driving next-gen diagnostics and targeted therapeutics. From decoding the human genome to unlocking personalized treatment paths, whole exome sequencing (WES) is reshaping how we understand and treat disease at the molecular level. Cracking the Code: Why Whole Exome Sequencing is the...